Drug Type Small molecule drug |
Synonyms Dapoxetine, Dapoxetine hydrochloride (USAN), Priligy + [2] |
Target |
Mechanism SERT inhibitors(Serotonin transporter inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date FI (01 Feb 2009), |
Regulation- |
Molecular FormulaC21H24ClNO |
InChIKeyIHWDIQRWYNMKFM-BDQAORGHSA-N |
CAS Registry129938-20-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D03649 | Dapoxetine Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Premature Ejaculation | FI | 01 Feb 2009 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Erectile Dysfunction | Phase 3 | - | 01 Dec 2004 | |
Sexual Dysfunction, Physiological | Phase 3 | - | 01 Nov 2004 |
Phase 3 | 495 | Placebo (PDE5I + Placebo (Baseline)) | mghcbefuba(mvydnyberq) = zzzlcqmabo rfizaitygq (klbdlupfby, zbcmipndiw - iznkxdnkcw) | - | 04 Nov 2012 | ||
Placebo (PDE5I + Placebo (Week 12)) | mghcbefuba(mvydnyberq) = ohsakcfkpv rfizaitygq (klbdlupfby, nyfmpeepao - ysytdzjqtw) |